MARKET

LITS

LITS

Lite Strategy Inc
NASDAQ
0.9851
+0.0274
+2.86%
After Hours: 0.9654 -0.0197 -2.00% 19:30 11/11 EST
OPEN
0.9580
PREV CLOSE
0.9577
HIGH
1.020
LOW
0.9315
VOLUME
107.21K
TURNOVER
--
52 WEEK HIGH
2.260
52 WEEK LOW
0.6888
MARKET CAP
29.44M
P/E (TTM)
-0.4785
1D
5D
1M
3M
1Y
5Y
1D
AI Price Prediction: Grok Prices Solana, Cardano and Litecoin for 2028. Which Gains the Most?
24/7 Wall St. · 8h ago
Lite Strategy reports Q1 results
Seeking Alpha · 1d ago
Lite Strategy Q1 EPS $0.48 Up From $(0.12) YoY
Benzinga · 1d ago
Press Release: Lite Strategy Reports Fiscal 2027 First Quarter Financial Results
Dow Jones · 1d ago
Weekly Report: what happened at LITS last week (1102-1106)?
Weekly Report · 2d ago
Lite Strategy, Inc. Reports Cashless Exercise of 517,509 Advisory Warrants by Green Dragon Investments LLC
NASDAQ · 11/03 23:11
Lite Strategy Reports Unregistered Equity Securities Issuance
TipRanks · 11/03 22:00
Weekly Report: what happened at LITS last week (1026-1030)?
Weekly Report · 11/02 09:15
More
About LITS
Lite Strategy, Inc. is a pharmaceutical company focused on developed and differentiated cancer therapies. The Company's drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, zandelisib, an oral, once-daily, selective PI3Kd inhibitor. CDK9 functions in cell cycle regulation, and its modulation in cancer and autoimmune diseases. It is a transcriptional regulator of the myeloid leukemia cell differentiation protein (Mcl-1). Zandelisib is an oral, once-daily, selective PI3Kd inhibitor that is developed for the treatment of indolent B-cell lymphomas. Its approach to pre-clinical drug development is to evaluate its drug candidates in combination with standard-of-care therapies to overcome known resistance mechanisms and address medical needs. It holds Litecoin (LTC) tokens as a primary asset as part of an institutional treasury. LTC is an open source, global payment network that is decentralized without any central authorities.

Webull offers Lite Strategy Inc stock information, including NASDAQ: LITS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LITS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LITS stock methods without spending real money on the virtual paper trading platform.